Amorphous formulations of indomethacin and griseofulvin prepared by electrospinning

Felipe L. Lopez; Gemma C. Shearman; Simon Gaisford; Gareth R. Williams

doi:10.1021/mp500391y

Amorphous formulations of indomethacin and griseofulvin prepared by electrospinning

Felipe L. Lopez, Gemma C. Shearman, Simon Gaisford, Gareth R. Williams

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	4327-4338
Journal	Molecular Pharmaceutics
Volume	11
Issue number	12
Early online date	3 Nov 2014
DOIs	https://doi.org/10.1021/mp500391y
Publication status	Published - 1 Dec 2014

Bibliographical note

Note: This work was supported by the Engineering and Physical Sciences Research Council [grant number EP/I01375X/1].

Keywords

Pharmacy

Access to Document

10.1021/mp500391y

Shearman-G-35696-VoRFinal published version, 4.15 MBLicence: CC BY

http://dx.doi.org/10.1021/mp500391y

Cite this

@article{ba50a0c325b64d149065a63de0ea6f13,

title = "Amorphous formulations of indomethacin and griseofulvin prepared by electrospinning",

keywords = "Pharmacy",

author = "Lopez, \{Felipe L.\} and Shearman, \{Gemma C.\} and Simon Gaisford and Williams, \{Gareth R.\}",

note = "Note: This work was supported by the Engineering and Physical Sciences Research Council [grant number EP/I01375X/1].",

year = "2014",

month = dec,

day = "1",

doi = "10.1021/mp500391y",

language = "English",

volume = "11",

pages = "4327--4338",

journal = "Molecular Pharmaceutics",

issn = "1543-8384",

publisher = "American Chemical Society",

number = "12",

}

TY - JOUR

T1 - Amorphous formulations of indomethacin and griseofulvin prepared by electrospinning

AU - Lopez, Felipe L.

AU - Shearman, Gemma C.

AU - Gaisford, Simon

AU - Williams, Gareth R.

N1 - Note: This work was supported by the Engineering and Physical Sciences Research Council [grant number EP/I01375X/1].

PY - 2014/12/1

Y1 - 2014/12/1

KW - Pharmacy

U2 - 10.1021/mp500391y

DO - 10.1021/mp500391y

M3 - Article

SN - 1543-8384

VL - 11

SP - 4327

EP - 4338

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

IS - 12

ER -